Natera’s Heart Test Can Better Detect Rejection for Transplant Patients
Natera launched Prospera Heart with Donor Quantity Score, enhancing its ability to detect rejection in heart transplant patients.
Natera launched Prospera Heart with Donor Quantity Score, enhancing its ability to detect rejection in heart transplant patients.
The Centers for Medicare & Medicaid Services has granted Advanced Diagnostic Laboratory Test status for the Signatera molecular residual disease test.
Natera’s genetic test evaluates the number of chromosomes in embryos to detect extra or missing chromosomes, and screens for inherited genetic disorders.